Meyers Health Care Institute, Worcester, MA, USA; UMass Chan Medical School, Worcester, MA, USA.
University of Maryland School of Medicine, Baltimore, MD, USA.
J Am Med Dir Assoc. 2022 Mar;23(3):345-349. doi: 10.1016/j.jamda.2021.11.034. Epub 2021 Dec 22.
An effective clinical research effort in nursing homes to address prevention and treatment of COVID-19 faced overwhelming challenges. Under the Health Care Systems Research Network-Older Americans Independence Centers AGING Initiative, a multidisciplinary Stakeholder Advisory Panel was convened to develop recommendations to improve the capability of the clinical research enterprise in US nursing homes. The Panel considered the nursing home as a setting for clinical trials, reviewed the current state of clinical trials in nursing homes, and ultimately developed recommendations for the establishment of a nursing home clinical trials research network that would be centrally supported and administered. This report summarizes the Panel's recommendations, which were developed in alignment with the following core principles: build on available research infrastructure where appropriate; leverage existing productive partnerships of researchers with groups of nursing homes and nursing home corporations; encompass both efficacy and effectiveness clinical trials; be responsive to a broad range of stakeholders including nursing home residents and their care partners; be relevant to an expansive range of clinical and health care delivery research questions; be able to pivot as necessary to changing research priorities and circumstances; create a pathway for industry-sponsored research as appropriate; invest in strategies to increase diversity in study populations and the research workforce; and foster the development of the next generation of nursing home researchers.
为了应对新冠疫情的预防和治疗,养老院中的有效临床研究工作面临着巨大的挑战。在美国卫生保健系统研究网络——老年人独立中心老龄化倡议下,成立了一个多学科利益相关者顾问小组,以制定建议,提高美国养老院临床研究机构的能力。该小组将养老院视为临床试验的场所,审查了养老院临床试验的现状,并最终为建立一个由中央支持和管理的养老院临床试验研究网络制定了建议。本报告总结了小组的建议,这些建议是根据以下核心原则制定的:在适当的情况下利用现有的研究基础设施;利用研究人员与养老院和养老院公司群体的现有富有成效的合作伙伴关系;包含疗效和有效性临床试验;对包括养老院居民及其护理伙伴在内的广泛利益相关者做出回应;与广泛的临床和医疗服务提供研究问题相关;能够根据研究重点和情况的变化进行调整;在适当的情况下为行业赞助的研究创造途径;投资于增加研究人群和研究人员多样性的策略;并促进下一代养老院研究人员的发展。